{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_2460", "batch_size": 36, "batch_pos": 33, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "No high-potency verb, metaphor, or other Q2 cue is present.", "method": "llm_batch", "batch_id": "batch_2_17488", "batch_size": 193, "batch_pos": 190, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "'secures' and 'includes' are not moderate verbs from the list. '665,000 doses' and '40 million vaccines' are scales but not paired with a moderate verb describing impact.", "method": "llm_batch", "batch_id": "batch_3_12452", "batch_size": 94, "batch_pos": 91, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_21296", "batch_size": 88, "batch_pos": 85, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_19560", "batch_size": 82, "batch_pos": 79, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser token or scale contrast.", "method": "llm_batch", "batch_id": "batch_6_19608", "batch_size": 23, "batch_pos": 20, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_19316", "batch_size": 199, "batch_pos": 196, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Mentions 'secures up to 665,000 doses' and 'option for a further 40 million vaccines' which are preparedness measures, without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_10000", "batch_size": 51, "batch_pos": 48, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
